Singapore, 18 April 2024— Horizon Quantum Computing, a company building software development tools for quantum computers, today announced that it is establishing a first-of-a-kind testbed for integrating quantum computing hardware with...
Sorriso is a biopharmaceutical company advancing a pipeline of disease-modifying antibodies for the treatment of immune-mediated diseases, including Crohn’s disease and ulcerative colitis. The company's platform generates potent antibodies that can be delivered orally and are designed to maintain activity throughout the human intestine.
© 2024 Pappas Capital, LLC. ALL RIGHTS RESERVED.